search
Back to results

Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery (FEMCAT)

Primary Purpose

Cataract

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Cataract surgery with Phacoemulsification
Femtosecond laser-assisted cataract surgery
Sponsored by
University Hospital, Bordeaux
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract focused on measuring cataract surgery, femtosecond laser cataract surgery, phacoemulsification, Cost-Benefit Analysis, Cost Effectiveness, Hospital Costs

Eligibility Criteria

22 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cataract with impaired visual acuity (> or equal +0.3 LogMAR) or with cataract-related visual symptoms (Halos, Monocular diplopia, glare)
  • French healthcare insurance beneficiary

Exclusion Criteria:

  • Pupil size lower than 6mm
  • Iris constriction
  • Iris synechiae
  • Preoperative zonular instability or crystalline lens subluxation
  • Obstructive Corneal scars
  • Obstructive pterygion
  • Axial length <20.5 mm
  • Corneal astigmatism >1.5 diopters
  • Fuchs corneal dystrophy
  • History of Central retinal vein or artery occlusion
  • History of uveitis
  • History of optic nerve head neuropathy except glaucoma
  • Progressive glaucoma
  • Nystagmus
  • Uncontrolled diabetes mellitus
  • General history of dementia or psychotic disorders
  • Pregnancy, breast feeding
  • General medications: Alpha-blockers, Carbonic anhydrase inhibitors

Sites / Locations

  • CHU de Bordeaux
  • CHU de Brest
  • Hospices Civils de Lyon
  • Hôpital Cochin
  • CHU de Tours

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Phaco

Femto

Arm Description

Cataract surgery by phacoemulsification

Corneal incision, anterior capsulorhexis and lens fragmentation by femtosecond laser

Outcomes

Primary Outcome Measures

Incremental Cost/effectiveness ratio defined as cost per incremental therapeutic success.
Therapeutic success will be defined by the association of the following criterion: No severe intraoperative or postoperative complications, Best Corrected Visual Acuity of 0 LogMAR, A refractive error inferior or equal to 0.75 diopter, Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°.

Secondary Outcome Measures

Quality of life
Quality of life evaluation using Visual Function 14 questionnaire
Learning curve of the femtosecond laser-assisted cataract surgery
Overall costs of cataract surgery in both arms from the hospital perspective
Incremental cost - Utility ratio defined as incremental Cost/QALY (Quality Adjusted Life Year) for healthcare insurance in both arms
No severe intraoperative or postoperative complications
Best Corrected Visual Acuity of 0 LogMAR
Refractive error inferior or equal to 0.75 diopter
Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°

Full Information

First Posted
October 21, 2013
Last Updated
October 2, 2018
Sponsor
University Hospital, Bordeaux
search

1. Study Identification

Unique Protocol Identification Number
NCT01982006
Brief Title
Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery
Acronym
FEMCAT
Official Title
Impact Médico-Economique de la Chirurgie de la cATaracte au Laser Femtoseconde
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
October 9, 2013 (Actual)
Primary Completion Date
December 15, 2016 (Actual)
Study Completion Date
December 15, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Bordeaux

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Cataract is the leading cause of blindness worldwide and cataract surgery is the most frequent surgery performed in France. A new technology, the femtosecond laser-assisted cataract surgery, has to be compared with phacoemulsification alone, the conventional cataract surgery, to determine the economic impact of femtosecond laser-assisted process for the French healthcare insurance.
Detailed Description
An estimated 700,000 cataract procedures are performed every year in France, with this amount of surgeries predicted to climb as the population there, as well as around the world, ages. Currently, phacoemulsification alone is the conventional cataract surgery. The femtosecond laser-assisted cataract surgery has to be compared with the standard process to provide information on how it could benefit the patient population treated every year for cataract surgery. This economic study has received a grant from the French Ministry of Health to evaluate the economic impact of femtosecond laser-assisted process for the French healthcare system. For this goal, this prospective, randomized, parallel, multicenter and simple blind study will determine the incremental cost/effectiveness ratio for femtosecond laser-assisted process versus phacoemulsification surgery. Visual acuity results and intraoperative or postoperative complication rate will be compared between both groups. The learning curve of the femtosecond laser assisted cataract surgery will be also evaluated for each surgeon involved in the study. Ethic and regulatory autority authorisations were obtained at 19/Dec/2012 and 15/Feb/2013, respectively. Date of first inclusion: 9/Oct/2013. Date of first NCT release: 13/Nov/2013. 30 patients were included between this period. French regulatory process dos not require NCT registration before first inclusion.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
cataract surgery, femtosecond laser cataract surgery, phacoemulsification, Cost-Benefit Analysis, Cost Effectiveness, Hospital Costs

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
920 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Phaco
Arm Type
Active Comparator
Arm Description
Cataract surgery by phacoemulsification
Arm Title
Femto
Arm Type
Experimental
Arm Description
Corneal incision, anterior capsulorhexis and lens fragmentation by femtosecond laser
Intervention Type
Procedure
Intervention Name(s)
Cataract surgery with Phacoemulsification
Intervention Description
Each patients randomized in the phaco arm will undergo a conventional cataract surgery. Corneal incisions will be manually performed using the same calibrated blade and at the same location for all procedures of one surgeon. Phacoemulsification machine used to perform cataract surgery in each center will be the same for all patients included in the center. The IOL (IntraOcular Lens) used in each center will be the same for all patients treated in the center.
Intervention Type
Device
Intervention Name(s)
Femtosecond laser-assisted cataract surgery
Intervention Description
Each patients randomized in the femto arm will undergo a femtosecond laser assisted cataract surgery. Corneal incisions will be performed by the laser. Number, size and location of the incisions must be the same than in the phaco arm for all patients treated by one surgeon. Phacoemulsification machine used to remove the liquefied lens will be the same than in the phaco arm The IOL used in each center will be the same than in the phaco arm
Primary Outcome Measure Information:
Title
Incremental Cost/effectiveness ratio defined as cost per incremental therapeutic success.
Description
Therapeutic success will be defined by the association of the following criterion: No severe intraoperative or postoperative complications, Best Corrected Visual Acuity of 0 LogMAR, A refractive error inferior or equal to 0.75 diopter, Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°.
Time Frame
3 months after inclusion
Secondary Outcome Measure Information:
Title
Quality of life
Description
Quality of life evaluation using Visual Function 14 questionnaire
Time Frame
Before surgery (From day -8 to day -1) and months 1, 3 and 12 after surgery
Title
Learning curve of the femtosecond laser-assisted cataract surgery
Time Frame
End of research (Month 12)
Title
Overall costs of cataract surgery in both arms from the hospital perspective
Time Frame
End of research (Month 12)
Title
Incremental cost - Utility ratio defined as incremental Cost/QALY (Quality Adjusted Life Year) for healthcare insurance in both arms
Time Frame
12 months after inclusion
Title
No severe intraoperative or postoperative complications
Time Frame
3 months after inclusion
Title
Best Corrected Visual Acuity of 0 LogMAR
Time Frame
3 months after inclusion
Title
Refractive error inferior or equal to 0.75 diopter
Time Frame
3 months after inclusion
Title
Corneal surgically-induced astigmatism inferior or equal to 0.5 diopter and a postoperative change of astigmatism axis inferior or equal to 20°
Time Frame
3 months after inclusion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cataract with impaired visual acuity (> or equal +0.3 LogMAR) or with cataract-related visual symptoms (Halos, Monocular diplopia, glare) French healthcare insurance beneficiary Exclusion Criteria: Pupil size lower than 6mm Iris constriction Iris synechiae Preoperative zonular instability or crystalline lens subluxation Obstructive Corneal scars Obstructive pterygion Axial length <20.5 mm Corneal astigmatism >1.5 diopters Fuchs corneal dystrophy History of Central retinal vein or artery occlusion History of uveitis History of optic nerve head neuropathy except glaucoma Progressive glaucoma Nystagmus Uncontrolled diabetes mellitus General history of dementia or psychotic disorders Pregnancy, breast feeding General medications: Alpha-blockers, Carbonic anhydrase inhibitors
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cédric SCHWEITZER, MD
Organizational Affiliation
University Hospital Bordeaux, France
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
BENARD Antoine, MD
Organizational Affiliation
University Hospital Bordeaux, France
Official's Role
Study Chair
Facility Information:
Facility Name
CHU de Bordeaux
City
Bordeaux
ZIP/Postal Code
33000
Country
France
Facility Name
CHU de Brest
City
Brest
ZIP/Postal Code
29609
Country
France
Facility Name
Hospices Civils de Lyon
City
Lyon
ZIP/Postal Code
69317
Country
France
Facility Name
Hôpital Cochin
City
Paris
ZIP/Postal Code
75679
Country
France
Facility Name
CHU de Tours
City
Tours
ZIP/Postal Code
37044
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
17067897
Citation
Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmol Clin North Am. 2006 Dec;19(4):415-25. doi: 10.1016/j.ohc.2006.07.008.
Results Reference
background
PubMed Identifier
15640920
Citation
Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004 Nov;82(11):844-51. Epub 2004 Dec 14.
Results Reference
background
PubMed Identifier
21088580
Citation
Lamoureux EL, Fenwick E, Pesudovs K, Tan D. The impact of cataract surgery on quality of life. Curr Opin Ophthalmol. 2011 Jan;22(1):19-27. doi: 10.1097/ICU.0b013e3283414284.
Results Reference
background
PubMed Identifier
7887161
Citation
Hovding G, Natvik C, Sletteberg O. The refractive error after implantation of a posterior chamber intraocular lens. The accuracy of IOL power calculation in a hospital practice. Acta Ophthalmol (Copenh). 1994 Oct;72(5):612-6. doi: 10.1111/j.1755-3768.1994.tb07188.x.
Results Reference
background
PubMed Identifier
18299059
Citation
Norrby S. Sources of error in intraocular lens power calculation. J Cataract Refract Surg. 2008 Mar;34(3):368-76. doi: 10.1016/j.jcrs.2007.10.031.
Results Reference
background
PubMed Identifier
9059242
Citation
Norregaard JC, Thoning H, Bernth-Petersen P, Andersen TF, Javitt JC, Anderson GF. Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study. Br J Ophthalmol. 1997 Feb;81(2):102-6. doi: 10.1136/bjo.81.2.102.
Results Reference
background
PubMed Identifier
7791051
Citation
Powell SK, Olson RJ. Incidence of retinal detachment after cataract surgery and neodymium: YAG laser capsulotomy. J Cataract Refract Surg. 1995 Mar;21(2):132-5. doi: 10.1016/s0886-3350(13)80499-3.
Results Reference
background
PubMed Identifier
8949710
Citation
Norregaard JC, Thoning H, Andersen TF, Bernth-Petersen P, Javitt JC, Anderson GF. Risk of retinal detachment following cataract extraction: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol. 1996 Aug;80(8):689-93. doi: 10.1136/bjo.80.8.689.
Results Reference
background
PubMed Identifier
21362773
Citation
Qatarneh D, Mathew RG, Palmer S, Bunce C, Tuft S. The economic cost of posterior capsule tear at cataract surgery. Br J Ophthalmol. 2012 Jan;96(1):114-7. doi: 10.1136/bjo.2010.200832. Epub 2011 Mar 1.
Results Reference
background
PubMed Identifier
20817344
Citation
Chatoux O, Touboul D, Buestel C, Balcou P, Colin J. [Crystalline lens photodisruption using femtosecond laser: experimental study]. J Fr Ophtalmol. 2010 Sep;33(7):472-80. doi: 10.1016/j.jfo.2010.06.008. French.
Results Reference
background
PubMed Identifier
21700099
Citation
Friedman NJ, Palanker DV, Schuele G, Andersen D, Marcellino G, Seibel BS, Batlle J, Feliz R, Talamo JH, Blumenkranz MS, Culbertson WW. Femtosecond laser capsulotomy. J Cataract Refract Surg. 2011 Jul;37(7):1189-98. doi: 10.1016/j.jcrs.2011.04.022. Erratum In: J Cataract Refract Surg. 2011 Sep;37(9):1742.
Results Reference
background
PubMed Identifier
21084720
Citation
Palanker DV, Blumenkranz MS, Andersen D, Wiltberger M, Marcellino G, Gooding P, Angeley D, Schuele G, Woodley B, Simoneau M, Friedman NJ, Seibel B, Batlle J, Feliz R, Talamo J, Culbertson W. Femtosecond laser-assisted cataract surgery with integrated optical coherence tomography. Sci Transl Med. 2010 Nov 17;2(58):58ra85. doi: 10.1126/scitranslmed.3001305.
Results Reference
background
PubMed Identifier
20494782
Citation
Masket S, Sarayba M, Ignacio T, Fram N. Femtosecond laser-assisted cataract incisions: architectural stability and reproducibility. J Cataract Refract Surg. 2010 Jun;36(6):1048-9. doi: 10.1016/j.jcrs.2010.03.027. No abstract available.
Results Reference
background
PubMed Identifier
15474830
Citation
Taketani F, Matuura T, Yukawa E, Hara Y. Influence of intraocular lens tilt and decentration on wavefront aberrations. J Cataract Refract Surg. 2004 Oct;30(10):2158-62. doi: 10.1016/j.jcrs.2004.02.072.
Results Reference
background
PubMed Identifier
20000286
Citation
Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg. 2009 Dec;25(12):1053-60. doi: 10.3928/1081597X-20091117-04.
Results Reference
background
PubMed Identifier
31954466
Citation
Schweitzer C, Brezin A, Cochener B, Monnet D, Germain C, Roseng S, Sitta R, Maillard A, Hayes N, Denis P, Pisella PJ, Benard A; FEMCAT study group. Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial. Lancet. 2020 Jan 18;395(10219):212-224. doi: 10.1016/S0140-6736(19)32481-X.
Results Reference
derived
PubMed Identifier
24974812
Citation
Schweitzer C, Hayes N, Brezin A, Cochener B, Denis P, Pisella PJ, Benard A; FEMCAT study group. Re: Abell et al.: Cost-effectiveness of femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (Ophthalmology 2014;121:10-6). Ophthalmology. 2014 Oct;121(10):e53-4. doi: 10.1016/j.ophtha.2014.05.025. Epub 2014 Jun 26. No abstract available.
Results Reference
derived

Learn more about this trial

Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery

We'll reach out to this number within 24 hrs